Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Bulletin of Experimental Biology and Medicine
Published in: Bulletin of Experimental Biology and Medicine 5/2006

01-11-2006 | General Pathology and Pathophysiology

Activities of prolyl endopeptidase and dipeptidyl peptidase IV in brain structures of rats with dopamine deficiency-dependent MPTP-induced depressive syndrome

Authors: N. A. Krupina, N. N. Zolotov, N. G. Bogdanova, I. N. Orlova, N. N. Khlebnikova, G. N. Kryzhanovskii

Published in: Bulletin of Experimental Biology and Medicine | Issue 5/2006

Login to get access
Metadata
Title
Activities of prolyl endopeptidase and dipeptidyl peptidase IV in brain structures of rats with dopamine deficiency-dependent MPTP-induced depressive syndrome
Authors
N. A. Krupina
N. N. Zolotov
N. G. Bogdanova
I. N. Orlova
N. N. Khlebnikova
G. N. Kryzhanovskii
Publication date
01-11-2006
Publisher
Kluwer Academic Publishers-Consultants Bureau
Published in
Bulletin of Experimental Biology and Medicine / Issue 5/2006
Print ISSN: 0007-4888
Electronic ISSN: 1573-8221
DOI
https://doi.org/10.1007/s10517-006-0416-5

Other articles of this Issue 5/2006

Bulletin of Experimental Biology and Medicine 5/2006 Go to the issue

OriginalPaper

Effect of 5HT2C-receptor agonist MK-212 on blood corticosterone level and behavior in mice

OriginalPaper

Neuroimmunomodulatory effect of antibodies against GABA on acute generalized and chronic epileptiform activity

OriginalPaper

Effect of chronic consumption of sodium valproate and melatonin on seizure activity in Krushinskii-Molodkina rats

OriginalPaper

Relationship between natural concentration of heavy water isotopologs and rate of H2O2 generation by mitochondria

OriginalPaper

Model of immunogenic uveitis in rabbits

OriginalPaper

Role of cannabinoid receptors in the regulation of cardiac contractility during ischemia/reperfusion
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits